期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Helicobacter pylori associated gastric intestinal metaplasia:Treatment and surveillance 被引量:23
1
作者 kevin sze-hang liu Irene Oi-Ling Wong Wai K Leung 《World Journal of Gastroenterology》 SCIE CAS 2016年第3期1311-1320,共10页
Gastric cancer(GC) is one of the leading causes of cancer related death in the world, particularly in East Asia. According to the Correa's cancer cascade, noncardia GC is usually developed through a series of muco... Gastric cancer(GC) is one of the leading causes of cancer related death in the world, particularly in East Asia. According to the Correa's cancer cascade, noncardia GC is usually developed through a series of mucosal changes from non-atrophic gastritis to atrophic gastritis(AG), intestinal metaplasia(IM), dysplasia and adenocarcinoma. Atrophic gastritis and IM are therefore generally considered to be pre-neoplastic gastric lesions. Helicobacter pylori(H. pylori) infection is an important initiating and promoting step of this gastric carcinogenesis cascade. Emerging long-term data showed that eradication of H. pylori reduced the risk of subsequent cancer development. It however remains confusing whether eradication of the bacterium in individuals with pre-neoplastic gastric lesions could regress these changes as well as in preventing cancer. Whilst H. pylori eradication could likely regress AG, the presence of IM may be a point of no return in this cascade. Hence, surveillance by endoscopy may be indicated in those with extensive IM or those with incomplete IM, particularly in populations with high GC risk. The optimal interval and the best tool of surveillance endoscopy remains to be determined in future studies. 展开更多
关键词 HELICOBACTER PYLORI GASTRIC cancer Intestinalmetaplasia TREATMENT SURVEILLANCE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部